Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pollard

Showing results (131-140 of 1,177) with videos related to

Pageof 118
Sort By:
Paediatric Drugs|September 2, 2004
Meningococcal vaccinesJens U Rüggeberg, Andrew J Pollard
Critical Reviews in Microbiology|May 31, 2017
The next chapter for group B meningococcal vaccinesN Y Wang, A J Pollard
Nature Materials|March 27, 2020
Vaccine communication in a digital societyTonia M Thomas, Andrew J Pollard
Methods in Molecular Medicine|February 22, 2011
Clinical studies : an overviewF A Riordan, A J Pollard
Human Vaccines|April 10, 2008
Sustaining immunity after immunization against encapsulated bacteriaGeraldine Blanchard-Rohner, Andrew J Pollard
Lancet (London, England)|January 18, 2013
The beginning of the end for serogroup B meningococcus?Matthew D Snape, Andrew J Pollard
Current Opinion in Infectious Diseases|April 20, 2002
Emerging infectious diseases in the 21st centuryAndrew J. Pollard, Simon R. Dobson
Expert Opinion on Biological Therapy|December 2, 2005
Towards an improved serogroup B Neisseria meningitidis vaccineKirsten P Perrett, Andrew J Pollard
The Journal of Infection|September 10, 2002
Respiratory syncytial virus infections in children and adultsC L Collins, A J Pollard
BMJ (Clinical Research Ed.)|April 26, 2003
Altitude illnessP W Barry, A J Pollard
Pageof 118

Showing results (131-140 of 1,177) with videos related to

Sort By:
Pageof 118
Paediatric Drugs|September 2, 2004
Meningococcal vaccinesJens U Rüggeberg, Andrew J Pollard
Critical Reviews in Microbiology|May 31, 2017
The next chapter for group B meningococcal vaccinesN Y Wang, A J Pollard
Nature Materials|March 27, 2020
Vaccine communication in a digital societyTonia M Thomas, Andrew J Pollard
Methods in Molecular Medicine|February 22, 2011
Clinical studies : an overviewF A Riordan, A J Pollard
Human Vaccines|April 10, 2008
Sustaining immunity after immunization against encapsulated bacteriaGeraldine Blanchard-Rohner, Andrew J Pollard
Lancet (London, England)|January 18, 2013
The beginning of the end for serogroup B meningococcus?Matthew D Snape, Andrew J Pollard
Current Opinion in Infectious Diseases|April 20, 2002
Emerging infectious diseases in the 21st centuryAndrew J. Pollard, Simon R. Dobson
Expert Opinion on Biological Therapy|December 2, 2005
Towards an improved serogroup B Neisseria meningitidis vaccineKirsten P Perrett, Andrew J Pollard
The Journal of Infection|September 10, 2002
Respiratory syncytial virus infections in children and adultsC L Collins, A J Pollard
BMJ (Clinical Research Ed.)|April 26, 2003
Altitude illnessP W Barry, A J Pollard
Pageof 118